收稿日期: 2016-11-10
网络出版日期: 2017-02-22
基金资助
广东省医学科研基金（B2013261）
The effect of anti-inflammatory treatment on the progress of diethylnitrosamine induced primary liver cancer
Received date: 2016-11-10
Online published: 2017-02-22
目的 观察抗炎治疗对二乙基亚硝胺（diethylnitrosamine,DEN）诱导原发性肝癌进展的影响。 方法 选取42只大鼠建立DEN诱导肝癌模型，随机分为3组，观察诱癌不同时期各组肝组织结节个数及肝组织结构的变化，用免疫组化检测3组CD68、CD206和CD34的阳性细胞表达，用western blot检测3组肝组织中TNF-α、IL10、TGF-β、HGF及NFκB等蛋白的相对表达。 结果 与对照组及葡醛内酯组相比，氢化可的松组结节个数更少，肝癌出现时间更晚，肝组织中CD68、CD206和CD34的阳性细胞表达更少，在诱癌第8~12周TNF-α、IL10、TGFβ、HGF和NFκB等蛋白在肝组织中的相对表达更少。 结论 抑制肝脏微环境中单核-巨噬细胞介导的慢性非特异性炎症能在诱癌早期延缓DEN诱导原发性肝癌的进展。
李香芝 , 钮红岺 , 刘晓珑 , 刘立新 . 抗炎治疗影响DEN诱导原发性肝癌进展的研究[J]. 中国临床解剖学杂志, 2017 , 35(1) : 37 -42 . DOI: 10.13418/j.issn.1001-165x.2017.01.008
Objective To investigate the influence of anti-inflammatory treatment on the progress of DEN induced primary liver cancer. Methods 42 rats which were fed with Diethylnitrosamine (DEN) solution to induce the rat model of liver cancer, and randomly divided into 3 groups. The nodule number and the structural change of liver tissue in each group were observed. CD68, CD206 and CD34 positive expression in liver tissue were detected by immunohistochemical staining in each group. Relative expression of TNF-α, IL10, TGF-β, HGF and NFκB in the liver tissue was detected by western blot in each group. Results Compared with the control group and glucurolactone group，hydrocortisone group's nodule number was fewer，the appearance time of liver cancer was postponed, the positive expression of CD68, CD206 and CD34 was fewer, the protein relative expression of TNF-α, IL10, TGF -β, HGF and NF kappa B was fewer at the 8th,10th, and 12th week. Conclusion Inhibiting the chronic nonspecific inflammation which is mediated by mononuclear - macrophage in liver microenvironment can delay the progress of the primary liver cancer in rats at an early stage which is induced by DEN.
[1] Coussens LM, Werb Z. Inflammation and cancer[J]. Nature,2002,420(6917):860-867.
[2] Sica A, Schioppa T, Mantovani A, et al. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy[J]. Eur J Cancer, 2006,42(6):717-727.
[3] Mantovani A, Sozzani S, Locati M, et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes[J]. Trends Immunol, 2002, 23(11):549-555.
[4] Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer[J]. Cell, 2010,140(6):883-899.
[5] Mitre-Aguilar IB, Cabrera-Quintero AJ, Zentella-Dehesa A. Genomic and non-genomic effects of glucocorticoids: implications for breast cancer[J]. Int J Clin Exp Pathol, 2015, 8(1):1-10.
[6] Smoak KA, Cidlowski JA. Mechanisms of glucocorticoid receptor signaling during inflammation[J]. Mech Ageing Dev, 2004, 125(10-11):697-706.
[7] Wang H, Wang X, Li X, et al. CD68+HLA-DR+ M1-like macrophages promote motility of HCC cells via NF-κB/FAK pathway[J]. Cancer Lett, 2014, 345(1):91-99.
[8] 郑飞，周文平，张巍，等. 大鼠肝癌诱导过程中肝癌干细胞标志及炎症因子的动态变化[J]. 中国组织工程研究, 2015, (19):3005~3009.
[9] Zhang N, Sun Q, Chen Z, et al. Homeostatic regulatory role of Pokemon in NF-κB signaling: stimulating both p65 and IκBα expression in human hepatocellular carcinoma cells[J]. Mol Cell Biochem, 2013, 372(1-2):57-64.
[10] Wang M. Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-I in response to TNF by a p38 MAPK-dependent mechanism[J]. Am J Physiol Regul Integr Comp Physiol, 2006, 291(4):R880-884.
/
| 〈 |
|
〉 |
京ICP备08002354号-3
